Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 11Carcinoma, Hepatocellular 7Colorectal Neoplasms 6Liver Neoplasms 5Rectal Neoplasms 4Colonic Neoplasms 4Pancreatic Neoplasms 3Lung Neoplasms 3Kidney Neoplasms 3Breast Neoplasms 3Pain 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Thymoma 1Small Cell Lung Carcinoma 1Sarcoma 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms 1Multiple Advanced Tumors After PD-1 Therapy Failure 1Mesothelioma, Malignant 1Jaundice, Obstructive 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Cancer Liver Metastases 1Biliary Tract Neoplasms 1Bile Duct Neoplasms 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

regorafenib 1Radiofrequency Ablation 1Nivolumab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Colorectal Cancer Liver Metastases × Radiofrequency Ablation × Clear all
NCT05485909 2022-08-03

Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM

Sun Yat-sen University

Phase 2 Unknown
32 enrolled
Gastrointestinal

Colorectal Cancer Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡